案例系列:达尔巴万辛在儿童阳性感染中未经标签使用
María Guillén-Martínez1,2, David Aguilera-Alonso3,4,5, Juan Luis Santos-Pérez6,7
1From the Department of Pediatrics, Hospital Universitario Doce de Octubre, Madrid, Spain.
The Pediatric infectious disease journal
|June 5, 2025
概括
达尔巴万辛作为安全有效的儿童格兰氏阳性感染巩固治疗方法具有前景. 这项现实研究发现93%的治愈率,支持其在儿科患者的使用.
科学领域:
- 儿童传染病 儿童传染病
- 药理学 药理学是指药理学的学科.
- 抗微生物治疗是一种抗微生物疗法.
背景情况:
- 越来越多的人对达尔巴万辛的兴趣越来越大,用于治疗格兰氏阳性感染.
- 关于儿科使用的有限研究.
- 达尔巴万辛具有长半衰期和良好的耐受性等优点.
研究的目的:
- 评估达尔巴万辛在西班牙儿童的实际有效性和安全性.
- 评估达尔巴万辛在儿科患者的整合治疗.
- 研究其在儿童感染的各种临床场景中的使用.
主要方法:
- 对18岁以下儿童的回顾性研究.
- 从西班牙3所大学医院收集到2024年6月30日的数据.
- 对达尔巴万辛的使用,适用和结果进行描述性分析.
主要成果:
- 包括15名儿科患者 (平均年龄为7.1岁).
- 常见的感染:内心炎和内血管感染;最常见的病原体:金黄色葡萄球菌.
- 90天后高治愈率 (93%);一名患者出现了皮疹和腹.
结论:
- 达尔巴万辛是一种潜在的安全和有效的整合治疗,用于重症儿科格拉姆阳性感染.
- 需要进一步的儿科研究来充分评估达尔巴万辛的作用.
- 了解多剂量疗法中的药理动力学至关重要.
相关概念视频
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
249
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
249
Pharmacokinetics in Pediatric Patients: Drug Excretion
214
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution
258
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
258
Pharmacokinetics in Pediatric Patients: Drug Metabolism
195
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
195
Drug Dosing: Infants and Children
257
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
257
Acute Pyelonephritis II: Diagnostic Studies and Management
323
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
323


